In a groundbreaking new study scientists have revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. The study, provides new insights into the often-overlooked impact of human-targeted drugs on the microbial communities that play a critical role in human health.
